Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis

Background: Previous studies found that 40-60% of the sarcoidosis patients suffer from small fiber neuropathy (SFN), substantially affecting quality of life. SFN is difficult to diagnose, as a gold standard is still lacking. The need for an easily administered screening instrument to identify sarcoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Voortman, Mareye, Beekman, Emmylou, Drent, Marjolein, Hoitsma, Elske, De Vries, Jolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2018
Materias:
Original Article: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170121/
https://www.ncbi.nlm.nih.gov/pubmed/32476921
http://dx.doi.org/10.36141/svdld.v35i4.7260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170121/
https://www.ncbi.nlm.nih.gov/pubmed/32476921
http://dx.doi.org/10.36141/svdld.v35i4.7260

Ejemplares similares